跳至主要内容
临床试验/IRCT20190210042676N27
IRCT20190210042676N27招募中2 期

Evaluation of safety and clinical efficacy of Firooz brand name fissure cream containing lanolin in improving the pain and severity of fissure lesions in lactating women

Firooz Health Group Company0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Lactating women aged 18 to 45 with term babies (weighing 2500 to 4000 grams)
  • General health
  • Signing the consent form for participation in the study
  • Breast pain from severity 1 to 3

排除标准

  • People with puerperal fever
  • A newborn suffering from jaw and mouth abnormalities such as short frenulum or oral infections
  • Mothers suffering from diabetes
  • Use of any local treatment for fissure three days before the study

研究者

发起方
Firooz Health Group Company

相似试验